# NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds

> **NCT02544061** · PHASE2 · COMPLETED · sponsor: **Neumedicines Inc.** · enrollment: 18 (actual)

## Conditions studied

- Colostomy Stoma

## Interventions

- **BIOLOGICAL:** NM-IL-12
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02544061
- **Lead sponsor:** Neumedicines Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2017-10-31
- **Final completion:** 2018-02-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02544061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02544061, "NM-IL-12 (rHuIL-12) in Subjects With Open Surgical Wounds". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02544061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*